Clinical Trial Update: ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the ATS-1 needle-free device for delivering Saizen (recombinant human growth hormone) in healthy volunteers. The study assessed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Saizen (somatropin)

Snippet

Sponsor: EMD Serono | Conditions: Healthy | Phase 1 | Status: COMPLETED